Journal Publications

  • R.J. Grable, D.P. Rohler, and S.KLA, “Optical tomography breast imaging,” Proc. SPIE 2979, 197-210 (1997).

  • R.J. Grable, S.L. Ponder, N.A. Gkanatsios, W. Dieckmann, P. Olivier, R.H. Wake, and Y. Zeng, “Optical computed tomography for imaging the breast: First Look,” Proc. SPIE 4082, 40-45 (2000).

  • D.M. Richter, “Computed tomographic laser mammography, a practical review,” Jpn J Radiol Technol 59(6), 687-693 (2003).

  • D. Floery, T. Helbich, C. Riedl, S. Jaromi, M. Weber, S. Leodolter, and M. Fuchsjaeger, “Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM®): Initial experience,” Invest Radiol, 40(6), 328-335 (2005).

  • M.E.E. Eid, H.M.H. Hegab, and A.E. Schindler, “Role of CTLM® in early detection of vascular breast lesions,” Egyp J Radiol Nucl Med 37(1), 6330643 (2006).

  • B. Bobek-Billewicz, M. Jurkowski, K. Steinhof-Radwanska, and E. Stobiecka, “Evaluation of laser computed tomography usefulness in differentiation benign and malignant breast lesions,” Pol Przegl Radiol 73(1), 27-31 (2008).

  • A. Poellinger, J. Martin, S. Ponder, T. Freund, B. Hamm, U. Bick, and F. Diekmann, “Near-infrared laser computed tomography of the breast: First clinical experience,” Acad Radiol 15, 1545-1553, (2008).

  • K. Steinhof-Radwanska, B. Bobek-Billewicz, E. Stobiecka, K. Gorczewski, D. Adamiak, G. Stasiak-Preis, and M. Sczasny, “Can the application of computed tomography laser mammography (CTLM®) in dense breast (category 3,4 according to ACR) examinations combined with x-ray mammography enhance the detection of breast cancer?” Pol Przegl Radiol 74(1), 21-24 (2009).

  • A. Poellinger, T. Persigehl, M. Mahler, M. Bahner, S. Ponder, F. Diekmann, C. Bremer, and T. Moesta, “Near-infrared imaging of the breast using omocianine as a fluorescent dye,” Invest Radiol. 46(11), 697-704 (2011).

  • F. Collettini, J.C. Martin, F. Diekmann, E. Fallenberg, F. Engelken, S. Ponder, T.J. Kroencke, B. Hamm, and A. Poellingerm, “Diagnostic performance of a near-infrared breast imaging system as adjunct to mammography versus X-ray mammography alone,” Eur Radiol ONLINE 9-27-11; not yet in print.

  • Jin Qi, Zhaoxiang Ye, ” CTLM® as an adjunct to mammography in the diagnosis of patients with dense breast,” Clinical Imaging 37 (2), 289 -294 (2013).

Clinical Case Posters

Past & Present Clinical Collaboration

Loading...
  • Institute of Oncology, Maria Sklodowska-Curie Memorial Cancer Center,
    Gliwice, Poland
  • Catholic University Hospital, Rome, Italy
  • MeDoc HealthCare Center, Budapest, Hungary
  • Tianjin Medical University s Cancer Institute and Hospital, Tianjin, China

Imaging Diagnostic Systems, Inc. (IDSI) is a medical device company located in Fort Lauderdale, Florida, engaged primarily in the research, development, and marketing of a non-invasive breast imaging system. Learn more »

HAVE QUESTIONS ABOUT THE CTLM® SYSTEM OR IDSI?

Ask Our Experts